(Q46202438)

20 December 2017

title

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity (English)

1 reference

20 December 2017

1 reference

Zhen Chen

2

0 references

Jason D. Christie

3

object named as

Jason Christie

1 reference

20 December 2017

author name string

Carmel Kealey

1

1 reference

20 December 2017

Caroline F Thorn

4

1 reference

20 December 2017

Alexander S Whitehead

5

1 reference

20 December 2017

Maureen Price

6

1 reference

20 December 2017

Frederick F Samaha

7

1 reference

20 December 2017

Stephen E Kimmel

8

1 reference

20 December 2017

publication date

1 March 2007

1 reference

20 December 2017

published in

Pharmacogenomics

1 reference

20 December 2017

volume

8

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

217-225

1 reference

20 December 2017

Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement.

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Management of haemorrhagic complications associated with oral anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Managing oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Genetic polymorphisms in assessing interindividual variability in delivered dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Clinical consequences of cytochrome P450 2C9 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.3.217

21 January 2018

Identifiers

DOI

10.2217/14622416.8.3.217

1 reference

20 December 2017

1 reference

20 December 2017